![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2017-05-22 Purchase | 2017-05-24 7:57 pm | G1 Therapeutics Inc. | GTHX | MedImmune Ventures Inc. 10% Owner | 75,000 | $15 | $1,125,000 | 3,484,536 (Direct) | View |
2017-11-20 Sale | 2017-11-22 10:13 am | G1 Therapeutics Inc. | GTHX | MedImmune Ventures Inc. 10% Owner | 200,000 | $20.01 | $4,002,000 | 3,284,536 (Direct) | View |
2017-12-01 Sale | 2017-12-05 09:17 am | G1 Therapeutics Inc. | GTHX | MedImmune Ventures Inc. 10% Owner | 133,906 | $19.75 | $2,644,644 | 3,150,630 (Direct) | View |
2017-05-17 Purchase(A) | 2017-12-13 11:46 am | G1 Therapeutics Inc. | GTHX | MedImmune Ventures Inc. 10% Owner | 75,000 | $15 | $1,125,000 | 3,409,536 (Direct) | View |
2017-12-15 Sale | 2017-12-18 5:48 pm | G1 Therapeutics Inc. | GTHX | MedImmune Ventures Inc. 10% Owner | 200,000 | $19.75 | $3,950,000 | 2,950,630 (Direct) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2017-05-22 Conversion | 2017-05-24 7:57 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MedImmune Ventures Inc. 10% Owner | 3,409,536 | $0 | 3,484,536 (Direct) | View |
2017-05-22 Conversion | 2017-05-24 7:57 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MedImmune Ventures Inc. 10% Owner | 7,142,857 | $0 | 3,484,536 (Direct) | View |
2017-05-22 Conversion | 2017-05-24 7:57 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MedImmune Ventures Inc. 10% Owner | 2,412,628 | $0 | 3,484,536 (Direct) | View |
2017-05-22 Conversion | 2017-05-24 7:57 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MedImmune Ventures Inc. 10% Owner | 673,128 | $0 | 3,484,536 (Direct) | View |